We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Silverman Leaves FDA; Oversaw Compliance Office Restructure
CDRH Office of Compliance Director Steve Silverman told senior staff that he was leaving the FDA last month to pursue opportunities outside the government. His last day at the agency was Jan. 16, according to an internal memo provided to GMP.